Federal Register #DEA-1690

DEA Considers Usona Institute Application to Import Schedule I Controlled Substances for Research

This opportunity involves the Drug Enforcement Administration (DEA) considering an application from Usona Institute for importer registration of Schedule I controlled substances for research and analytical use. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - Applicant/Vendor: - Usona Institute - Products/Controlled Substances Requested: - Mescaline (Part Number: 7381) - 5-Methoxy-N-N-dimethyltryptamine (Part Number: 7431) - Dimethyltryptamine (Part Number: 7435) - Psilocybin (Part Number: 7437) - Psilocyn (Part Number: 7438) - All substances are Schedule I controlled substances - Quantities not specified - Purpose and Restrictions: - Importation strictly for research and analytical purposes - No use for clinical trials or human consumption - No other activities authorized under this registration - Notable Requirements: - DEA is accepting comments, objections, and hearing requests from registered bulk manufacturers and applicants - Place of Performance: - Usona Institute, Fitchburg, Wisconsin - Contracting Office: - DEA, Springfield, Virginia

Description

Usona Institute has applied to be registered as an importer of basic classes of controlled substances for research and analytical purposes. The substances will not be used for clinical trials or human consumption, and no other activities are authorized under this registration. Interested parties, including registered bulk manufacturers, may submit comments or objections and request a hearing by April 29, 2026. The application is managed by the Drug Enforcement Administration under the Justice Department.

View original listing